Multiple Imputation Approaches for Missing Time-to-Event Outcomes with Informative Censoring: Practical Considerations from a Simulation Study Based on Real Data
DOI:
https://doi.org/10.54103/2282-0930/28145Keywords:
missing data, multiple imputations, survival analysis, informative censoringAbstract
Missing outcomes data represent a common threat to the validity and robustness of clinical trials with time-to-event outcomes. Recent extensions of multiple imputations (MI), namely controlled-MI, have been introduced as a viable approach for sensitivity analysis in the presence of informative censoring, yet they lack validation based on real data. In this study we used data from a randomized trial to generate realistic scenarios of censoring mechanisms and compare several imputation approaches for missing outcome data. Our results confirm the relevance of multiple imputations especially in studies with long follow-up and higher proportion of potentially informative censoring.
Downloads
References
Bell ML, Fiero M, Horton NJ, Hsu CH. Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol. 2014;14:118. DOI: https://doi.org/10.1186/1471-2288-14-118
The Prevention and Treatment of Missing Data in Clinical Trials. Washington (DC)2010.
Groenwold RH, Donders AR, Roes KC, Harrell FE, Jr., Moons KG. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012;175(3):210–7. DOI: https://doi.org/10.1093/aje/kwr302
Altman DG. Missing outcomes in randomized trials: addressing the dilemma. Open Med. 2009;3(2):e51–3.
Tan PT, Cro S, Van Vogt E, Szigeti M, Cornelius VR. A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data. BMC Med Res Methodol. 2021;21(1):72. DOI: https://doi.org/10.1186/s12874-021-01261-6
Jackson D, White IR, Seaman S, Evans H, Baisley K, Carpenter J. Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation. Stat Med. 2014;33(27):4681–94. DOI: https://doi.org/10.1002/sim.6274
Cro S, Morris TP, Kenward MG, Carpenter JR. Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide. Stat Med. 2020;39(21):2815–42. DOI: https://doi.org/10.1002/sim.8569
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347–57 DOI: https://doi.org/10.1056/NEJMoa1812389
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Andrea Bellavia, Min Guo, Sabina Murphy

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Funding data
-
AstraZeneca United States
Grant numbers Institutional research grant to Brigham and Women’s Hospital


